Steroid-Releasing S8 Sinus Implant for Recurrent Nasal Polyps (RESOLVE)
A Clinical Evaluation of the Safety and Efficacy of the Steroid-Releasing S8 Sinus Implant Used in Post-Sinus Surgery Patients With Recurrent Sinus Obstruction
Sponsor: Intersect ENT
This PHASE2/PHASE3 trial investigates Chronic Sinusitis and Nasal Polyps and is currently completed. Intersect ENT leads this study, which shows 10 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE2_PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
▶ Show 5 earlier versions
-
Aug 2018 — Nov 2020 [monthly]
Completed PHASE2_PHASE3
-
Jun 2018 — Aug 2018 [monthly]
Completed PHASE2_PHASE3
-
Apr 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
-
Feb 2017 — Apr 2017 [monthly]
Completed PHASE2_PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2_PHASE3
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Intersect ENT
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Albany, United States , Atherton, United States , Atlanta, United States , Berkeley Heights, United States , Bethlehem, United States , Charleston, United States , Chicago, United States , Colorado Springs, United States , Lake Success, United States , Los Angeles, United States and 9 more locations